Company Overview
Snapshot
Founded in November 2024 by Shirel Attia, SleepAI is an early-stage company with 1–10 employees. The company has raised $820,000 across one funding round from one investor. SleepAI is developing an AI-based medical monitoring system for obstructive sleep apnea (OSA) and sleep disorders, with its technology undergoing successful clinical validation at a leading hospital.
Business overview
SleepAI offers an AI-based medical monitoring system designed to provide accurate, accessible, and scalable detection of obstructive sleep apnea (OSA) and other sleep disorders. The company's core technology leverages oximetry signal analysis to detect all levels of OSA severity with clinical-grade accuracy comparable to polysomnography (PSG). This solution enables non-invasive, multi-night, at-home or in-hospital diagnosis, sleep stage classification, and continuous patient monitoring. SleepAI targets the global healthcare market, aiming to improve patient outcomes and reduce healthcare costs by addressing the critical gap in sleep disorder detection and management.
Strategic signal
SleepAI's technology has been the subject of multiple research publications, including a May 2025 article in onlinelibrary.wiley.com detailing the clinical validation of its AI algorithms for OSA diagnosis and sleep staging from oximetry and photoplethysmography. This ongoing academic validation underscores the scientific rigor and potential clinical efficacy of SleepAI's solution, signaling a strong foundation for its medical monitoring system and its potential to disrupt traditional sleep diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- When was SleepAI founded and by whom?
- SleepAI was founded in November 2024 by Shirel Attia.
- What is the core technology behind SleepAI's solution?
- SleepAI's core technology utilizes oximetry signal analysis combined with deep learning algorithms to detect sleep apnea severity and classify sleep stages with clinical-grade accuracy.
- Has SleepAI's technology undergone clinical validation?
- Yes, SleepAI's technology has undergone successful clinical validation at a leading hospital, as detailed in a May 2025 publication in onlinelibrary.wiley.com.
- What is the total funding SleepAI has raised?
- SleepAI has raised a total of $820,000 in a Pre-Seed round in December 2024 from eHealth Ventures.
- What is SleepAI's primary target market?
- SleepAI targets the global healthcare market, aiming to improve patient outcomes and reduce healthcare costs by addressing the critical gap in sleep disorder detection and management.